<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220830055829N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-09-24</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>The effect of neuromuscular exercises on female runners with shin splints.</public_title>
      <acronym></acronym>
      <scientific_title>The effect of neuromuscular training on pain, proprioception, balance and selected functional tests in women runners with shin splints.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-09-24</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>24</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/65561</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Other, Purpose: Supportive, Randomization description: In this study, we will use the limited randomization method for all study groups with equal sample size, and among the types of limited randomization methods, we will use the assigned law randomization to achieve a balance in the number of people assigned to the study groups. First, we write the names of 24 people on the ball and put them in the box. We remove the balls from the box at random and without replacement. The 12 balls that we took out of the box at the beginning are called the intervention group and the 12 balls that are left are called the control group. Since it is not possible to reveal the random sequencing and to know the next assignment, concealment will not be performed.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Shin splint.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the neuromuscular training program, athletes are asked to follow their normal preseason track program and complete the neuromuscular training at the end of each session (weeks 1-6) after a 10-minute rest. The intervention period will be six weeks and will include three weekly training sessions. The duration of each training session is 30 minutes. Intervention 2: Control group: The control group will do their usual athletic training during this period.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data related to people who participate as a sample in this research will be shared after de-identification.

When:
The access period starts 6 months after the results are published.

To whom:
The documents of this research are available to researchers working in academic institutions, athletics federations and sports coaches.

Conditions:
Responsible people in sports in order to prevent injury, educational centers where there are people with problems mentioned in the research.

Where to obtain:
Saideh Loghmani Abdani
phone: 00989176478965
Email: S.loghmani5486@yahoo.com

How to obtain:
Checking the application, checking the applicant's documents, sending the required documents

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Saeeda Loqmani Abdani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University Blvd,  Arghvanieh,  East J St., Esfahan</address>
        <city>Esfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8155139998</zip>
        <telephone>+98 31 5353 4001</telephone>
        <email>s.loghmani5486@yahoo.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Saideh Loghmani Abdani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University Blvd,  Arghvanieh,  East J St., Esfahan</address>
        <city>Esfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8155139998</zip>
        <telephone>+98 31 5353 4001</telephone>
        <email>s.loghmani5486@yahoo.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Female gender
Placement in the age range of 17 to 23 years
The presence of shin splints
Athletics athlete</inclusion_criteria>
      <agemin>17 years</agemin>
      <agemax>23 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Absence in 3 sessions of practice
Causing injury during the training period
Reluctance to continue participating in training
Existence of injuries such as ACL injury, muscle tear and meniscus tear.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M76.81</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Anterior tibial syndrome</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the neuromuscular training program, athletes are asked to follow their normal preseason track program and complete the neuromuscular training at the end of each session (weeks 1-6) after a 10-minute rest. The intervention period will be six weeks and will include three weekly training sessions. The duration of each training session is 30 minutes.</i_keyword>
      <i_keyword>Control group: The control group will do their usual athletic training during this period</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: The beginning of the study (before the intervention) and 6 weeks after that. Method of measurement: A visual scale is used to measure leg pain. It is like a line 100 mm long, where the number zero indicates the absence of pain and the number 10 indicates the maximum amount of pain. According to the amount of pain they have had in the past 24 hours, the subjects draw a line around the stickers that are on the ruler and express the intensity of the pain, then by measuring the desired point, the intensity of the pain is measured in millimeters. . Numbers in the range of 0-10 mm indicate no pain, 10-30 mm indicate mild pain, 40-60 mm indicate moderate pain, and 70-100 mm indicate severe pain.</prim_outcome>
      <prim_outcome>Static balance. Timepoint: The beginning of the study (before the intervention) and 6 weeks after that. Method of measurement: To evaluate static balance, standing on one leg test is used. The subject takes off his shoes and clasps his hands in his arms, then bends his other leg at the knee and places his toe on the inside of the knee of the other leg. Then the subject separates the heel of the other foot from the ground and balances on one leg. The timer starts when the heel is off the ground and stops when one of the following errors occurs: hands are separated from the hips, leg on the knee is separated from the knee, weight-bearing leg is unbalanced so that the heel of the weight-bearing foot comes into contact with the ground.</prim_outcome>
      <prim_outcome>Dynamic balance. Timepoint: At the beginning of the study, before the start of the intervention, and 6 weeks after. Method of measurement: To evaluate the dynamic balance, the adjusted Y balance test is used. The method of conducting the test will be in such a way that the subject will be informed about the test through the explanation of the researcher and will do it several times as a practice before the main test. Then, in the main performance, the subjects stood on one leg in the center of the intersection of the lines, while standing on one leg, the subject was asked to reach with his free leg in the anterior, posterior internal, and posterior external directions. The method of performing the test was that the person stands on his right foot and performs the reaching action three times in the front path, and then stands on the left foot and performs the reaching action three times in the front path. The internal posterior and external posterior are also repeated. In this test, people's leg length affects their reaching distance. As mentioned, in order to normalize this test, the average reaching distance is divided by the leg length of each subject and multiplied by 100 to calculate the dependent variable and the reaching distance is obtained as a percentage of the leg length.</prim_outcome>
      <prim_outcome>Deep feelings. Timepoint: At the beginning of the study, before the start of the intervention, and 6 weeks after. Method of measurement: In this study, a goniometer will be used to evaluate proprioception. To start, the subject's ankle is dorsiflexed at an angle of 10 degrees, and then the foot returns to the first position, and the subject is asked to recreate the desired angle with closed eyes. In this situation, the amount of error is evaluated in degrees with a goniometer.</prim_outcome>
      <prim_outcome>Side jump. Timepoint: At the beginning of the study, before the start of the intervention, and 6 weeks after. Method of measurement: The objective of this test is for a person to jump from one side to the other over an obstacle (60 x 4 x 2 cm) as quickly as possible within a time span of 15 seconds. The person is instructed to keep their legs together. The number of correct jumps in two trials is recorded.</prim_outcome>
      <prim_outcome>Single leg jump. Timepoint: At the beginning of the study, before the start of the intervention, and 6 weeks after. Method of measurement: The person is instructed to hop on one foot at a time; After a successful jump with each foot, the height increases by adding new blocks (50 cm, 20 cm, 5 cm). The subject will have three attempts at each height and on each leg. Three, two or one points are awarded for successful completion of the first, second or third test. A maximum of 27 points can be awarded for each leg (maximum 54 points).</prim_outcome>
      <prim_outcome>Shifting platforms. Timepoint: At the beginning of the study, before the start of the intervention, and 6 weeks after. Method of measurement: The subject will start the test by standing with both feet on a platform (25 x 25 x 2 cm; 0.5 kg) supported on four legs and 3.7 cm high. The subject holds the second identical platform in his hands. He is then instructed to place the second platform next to the first platform and then step on it. Then he takes the first platform and places it next to the second platform and the person steps on it. This state lasts 20 seconds. Two points are awarded for each successful transfer from one platform to another (one point for moving the platform and another for moving the body to the second platform). The number of points in the interval of 20 seconds for two tests is recorded and summed up. If the person falls off the platform in this process, he gets back on the platform and continues the experiment.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-05-30</approval_date>
        <contact_name>Ethical Committee of Isfahan Azad University (Khorasgan)</contact_name>
        <contact_address>Esfahan, East J St., Arghwanieh, University Blvd Esfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
